Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bi-citrate
2. Biselic
3. Bismofarma
4. Bismuth Subcitrate
5. Bismuth Tripotassium Dicitrate
6. Colloidal Bismuth Subcitrate
7. De-nol
8. De-noltab
9. Denol
10. Gastrodenol
11. Sucrato
12. Tripotassium-dicitrato Bismuthate
13. Ventrisol-polfa
1. 813-93-4
2. Bismuth(iii) Citrate
3. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Salt (1:1)
4. N04867y76n
5. Bismuth Citrate [usp:usp]
6. Bi-citrate
7. Unii-n04867y76n
8. Einecs 212-390-1
9. Bismuth Citrate (usp)
10. Ec 212-390-1
11. Tegokat 752
12. Schembl41916
13. Bismuth, (citrato(3-))-
14. Bismuth Citrate [inci]
15. Citric Acid Bismuth(iii) Salt
16. Bismuth Citrate [mart.]
17. Dtxsid6074330
18. Bismuth Citrate [usp-rs]
19. Bismuth Citrate [who-dd]
20. Chebi:157700
21. Mfcd00050817
22. Akos015839589
23. Bismuth Citrate [usp Monograph]
24. D08875
25. Bismuth(3+) 2-hydroxypropane-1,2,3-tricarboxylate
26. 2-hydroxy-1,2,3-propanetricarboxylic Acid Bismuth Salt
27. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth (3+) Salt (1:1)
Molecular Weight | 398.08 g/mol |
---|---|
Molecular Formula | C6H5BiO7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | 397.98393 g/mol |
Monoisotopic Mass | 397.98393 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 211 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Antacids
Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Bismuth Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bismuth Citrate, including repackagers and relabelers. The FDA regulates Bismuth Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bismuth Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bismuth Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bismuth Citrate supplier is an individual or a company that provides Bismuth Citrate active pharmaceutical ingredient (API) or Bismuth Citrate finished formulations upon request. The Bismuth Citrate suppliers may include Bismuth Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Bismuth Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bismuth Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Bismuth Citrate active pharmaceutical ingredient (API) in detail. Different forms of Bismuth Citrate DMFs exist exist since differing nations have different regulations, such as Bismuth Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bismuth Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Bismuth Citrate USDMF includes data on Bismuth Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bismuth Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bismuth Citrate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bismuth Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bismuth Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bismuth Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bismuth Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bismuth Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bismuth Citrate suppliers with NDC on PharmaCompass.
Bismuth Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bismuth Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bismuth Citrate GMP manufacturer or Bismuth Citrate GMP API supplier for your needs.
A Bismuth Citrate CoA (Certificate of Analysis) is a formal document that attests to Bismuth Citrate's compliance with Bismuth Citrate specifications and serves as a tool for batch-level quality control.
Bismuth Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Bismuth Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bismuth Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bismuth Citrate EP), Bismuth Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bismuth Citrate USP).
LOOKING FOR A SUPPLIER?